A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. Market . Energy. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. Created with Sketch. 616553. Created with Sketch. . 971M ! Add to my watchlist. rights. Share Step 1. We love cruising, but this multi billion dollar industry has effectively been shut down. . 0¢. I look forward to holding SPL at task - this will be the third time I have been involved in pushing for a shareholder class action, which I can say on the previous two occasions resulted in a more communicative and transparent company, which ultimately is what I. Created with Sketch. Share Google Eddy Sunarto to read article about Starpharma stopping the next disease outbreak this is a great article about Viraleze the comments from CEO Jackie Fairley may suggest she is already aware of the results coming out of London imo. Forums. SPL. 28pm 13/11/2023 ? TMG (ASX) Chart. 59pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. And he still is Chairman or Director of SIX other companies. Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. Yes I am sure @sarge17 some will come on here today that have been predicting a $2 share price for more than 6 months because it has finally hit that target today saying “I toldNotification of cessation of securities - SPL. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. We would like to show you a description here but the site won’t allow us. ASX - Day Trading. . 72. Created with Sketch. The CEO chose to drop a throwaway line at the end of her presentation to potential investors as reported by Antibotter ie “ Starpharma are pursuing registration in China for Viraleze “ as one of if not the biggest market in the world one would think this is a price sensitive comment after all it was said as bait to potential investors. 5¢. . 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. ASX - By Stock. However, the interim results from ongoing Phase One NCT04865419 (the most advanced trial) was a little underwhelming IMO. 16,364,160. 50 or thereabouts. Safety, tolerability and side effects appear to be superior to all the base drugs, and that should be enough to sell the licenses. ASX - By Stock. Created with Sketch. SPL Price at posting: 14. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - By Stock. Share It would be silly to be tight on cash. The thread is titled so that it can be found and general enough so as to. Last updated 15. . Maybe SPL is frustrated at the lack of promotion, or maybe they have frustrated McKesson with continuity of supply, but I doubt it this early in the relationship - the logistics will be guided by demand, and it takes time to find the right equilibrium without overcommitting funds and/or scaling up manufacturing capacity, honouring contracts etc. And it’s at least good to see that the ASX has demanded supplementary information from Starpharma on numerous occasions recently. Forums. Forums. Click for more information. $0. yet if one considers that the amount of millions of shares via option they. Twenty years later it’s 84. Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. . Interesting write-up. I recommend that everyone sees the below. ACCELERATE RESOURCES LIMITED. If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc . The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. Release Date: 27/06/22 09:19; Summary: SPL signs expanded DEP research agreement with US Biopharma; Price Sensitive: Yes; Download Document 194. caBC OnLine Partnership Office E161, 4000 Seymour Place PO Box 9412, Stn Prov Govt Victoria, BC V8W 9V1Share. Created with Sketch. 0 Created with. m. Discussion. It is now more than ever that SPL needs to communicate with the market and keep everyone informed of any updates, because the radio silence and smoke and mirrors approach is evidently NOT WORKING. Think SPL has a valuation of 500mil…based on potential, or just promise. Join the HotCopper ASX share market forum today for free. Forums. This is what faces SPL's DEP product business, and so far they seem incapable of fighting through the maze to get recognised and accepted. Click for. This of course is on the back of long-serving lap dog and CFO/Secretary Nigel Baade resigning around the same time that the ASX asked Starpharma questions regarding continuous disclosure obligations and also whether a SPL announcement was tantamount to ramping. Even Pfizer won’t comment on him. Market Cap $. My understanding is this condition has not been met however each KMP has received 191,152 rights for this alongside other staff whose allocation will no doubt vary according to the capacity of their employment. 04KBIMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. Created with Sketch. 0¢ Sentiment: Buy. And that is my opinion too but about SPL. ASX - Day Trading. Share Many media conferences during the Pandemic we heard of Victorian initiatives for covid treatments or preventative by Dan Andrews or Brett Sutton - so VICTORIA has questions to answer. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. ASX - General. But the products were developed as proof of a saleable dendrimer product. Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. 2663916. Zeus Resources Limited is an Australia-based mineral exploration company. StarPharma Holdings Ltd. New Zealand Dollar. Latest Posts | Join the HotCopper forum today for free, page-1. *talks with BIG multinational Company, should've already taken place with deals completed and signed soon after the trial. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Imo HotCopper posters must have an. It is, to me, incredibly frustrating that SPL releases a good report with great promise and income mentions yet the market response is LIMP with a rise of. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. Advertise on HotCopper. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Commodities. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 70. Market . . . Over the 3 year period the index has remained at around 40,000 whereas the SPL SP has dropped around 70%. 3. 45K. 32 , that is a daily rise of over 50% on the market capital at the time it hit that low. ASX - Short Term Trading. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no deal/licence forthcoming. 10/10/23. ASX - General. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Latest Posts. Antibotter despite you starting 23 separate Starpharma threads in 3 weeks you do not own this Hotcopper forum. 129294. $0. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Some have been mentioned on this thread previously. 26. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. ASX - By Stock. News: SPO Spotless Group To Be Removed From Official List Of ASX Ltd At Close Of Trading On 30 Aug. ASX - By Stock. 5,006,219 was the total short sales as of 21/07/23 (1. But I’ve been having a. . Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. ASX - By Stock. Created with Sketch. 2. 8¢. I can't guess where or what or when, perhaps there is an informed opinion out there in HC SPL land but we have a very tight market and some. Click for more information. Last updated 15. ASX - By Stock. Eight (8) contributors to the HC SPL thread made price predictions (thank. I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. Just as I thought - both @antibotter and JF & Co. . I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. The matter has been adjourned to. but hey don't take my word for it, see for yourself in the official SPL ASX announcement dated 17th April 2023 You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. 12. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". When a board member uses rheir own hard earned cash and buys $350,000 worth of shares. 5¢ STARPHARMA HOLDINGS LIMITED - Discussion. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 75802. 50 or. Advertise on HotCopper. Share Yes, this is pre-clinical data, HOWEVER, on this occasion this positive data (of adding Starpharma’s conjugate to IO drugs) directly supports commercial negotiations for the soon to be released top-line results for DEP-Irinotecan, in my opinion. 70. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. 15. I’ve seen numerous cases across Hotcopper where a shareholder with a large investment will say whatever it takes, over a sustained period of years, even though it may be highly optimistic, knowingly false or misleading, in an attempt to protect their own investment, even at the expense of other less experienced Hotcopper members and investors. Market . Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. Notice to Sellers of Vapour Products – PST Rate Increase to 20% Page 3 of 3 Need more info? Online: gov. 10 Year Chart looks like a rollercoaster:But the spike in volume over the past month suggests:a) We're near a huge breakoutORb) We're near a huge. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. I should declare that I am. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 63M. SUBMISSION STEPS. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Created with Sketch. This is a charting thread for those interested in the movements of the SPL SP. Hey, "smart", I concur with your message. ASX - General. Talk with one of our capital. 0¢. ASX - Short Term Trading. Latest Posts. 56. SPL. ASX - General. Forums. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on PANCONTINENTAL ENERGY NL. . . IMO they haven't . If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . and as I said I met @Domesticgod there, which was a pleasure. Latest Posts. Provide some keywords to assist in categorisation of your abstract. Forums. Market Cap $58. ASX - Day Trading. 40. Last updated 15. Market . . 0834. 57pm 13/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. Join the HotCopper ASX share market forum today for free. Based on SPL's announcements and on reports of the AGM, my opinion is that the tune of the song that SPL sings never changes. by other companies i meant those associated with SPL, and ask what up from their end. 36. Share New future tech coming Antibody fragment-nanoparticle therapeutic eradicates cancerPosted YesterdayA multi-institutional team of researchers found novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicating gastric cancer in treated mice. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. ASX - By Stock. ASX - Day Trading. Volume. 0. , page-2. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Shouldn’t company have announced departure of key person when. 0¢. Forums. SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. Market . As of 2015, HotCopper was in the top 170 websites in Australia and was. Join the HotCopper ASX share market forum today for free. Volume. . 3¢. 73. 6. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. The matter has been adjourned to. However, just a word of caution before the usual pumping starts by the usual suspects. ASX - By Stock. 19/09/23. HotCopper has news, discussion, prices and market data on TRIGG MINERALS LIMITED. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased. SPL has great optionality, potential and a healthy balance sheet to ride out the current storm. Latest Posts. OR no reponse at all. 5¢. 8¢. Attached link highlights some of the complexities involved more broadly. Hey, "smart", I concur with your message. . We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Charts. Application for quotation of securities - SPL. ASX - Day Trading. Join the HotCopper ASX share market forum today for free. Join the HotCopper ASX share market forum today for free. . 56am 20/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. Jackie Fairley says: “Clearly we are surprised and extremely disappointed. This is just a lifestyle company at this point, management just keeping the company afloat with announcements that have no tangible impact on the share price while they collect their salaries. Created with Sketch. . Created with Sketch. Its a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. The usual suspects on Hotcopper were pumping the Hong Kong and Macau ’deal’ last year as a game changer and rivers of gold were going to flow across the border from China for Viraleze, apparently. . . ASX - Day Trading. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Since September 2020 the. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Advertise on HotCopper. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. I think that the more time that passes without profits, the less likely that there will ever be profits. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Join the HotCopper ASX share market forum today for free. ASX - General. . Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. Twelve month SPL daily chartSame old trend continues. All ETFs by Morningstar Ratings Morningstar Medalist Rating Gold. Comments. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. Market Cap $55. 5¢. Search for Betafem BV, Fleurstat or Viraleze and you will often get competing products but no reference to what you searched for (that is the way Google works). Views. 5¢ Sentiment: Hold Disclosure: HeldThat's so funny col69 Antibotter post had you scrambling to find the link where he got that information then you copy paste the link and infer you knew already, if you did know you would for sure have posted this morning, some posters knew you were not one of them imo, still should have been an announcement let's hope results once collated. ASX - By Stock. Model # 407730 Store SKU # 1000846365. This product was expected to produce rivers of. They not even have a license with SPL, just a basic research agreement. 9¢. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). . and the Government Medical Research Fund which provided $1mil to SPL to aid in developing Viraleze. Only 12 episodes made but so Iconic . Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. Each to their own. A correctly formatted example follows: Title of my presentation for the conference. To make matters worse he has AZD0466 on hold through no fault of the dendrimer technology, which appears to be highly successful in dealing with the drugs toxicity. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 37 Sentiment: Buy Disclosure: Held. 6% (1. As always, she is happy to hoover up freebie shares in the grandiose remuneration agreements as well as collect performance bonuses as disclosed in the Annual Report. 0000. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. He doesn't "hold" but 99% of his posts are on SPL, including a remarkable 350 in the last two months alone. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. . In March 2020 the SPL share price dropped to a low of 0. 38. Your statement below masquerading as a fact could mislead less experienced investors on this Hotcopper forum. 5¢ Sentiment: Sell Disclosure: Not HeldThe one positive sign is that AstraZeneca are continuing to expand site recruitment for both AZD0466 trials. 5. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). In SPL's case there is clearly another. HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. Yes I think SPL does have a future but TIME is of the essence. Created with Sketch. The sycophants, pompom-wavers, management apologists, cheerleaders and perennial uprampers of SPL on a Hotcopper know who they are. Join the HotCopper ASX share market. . Below are 3 charts showing the predictions for Starpharma's Price by End 2019. 7¢. Created with Sketch. ASX - Day TradingIn my opinion, most rational people would have to concede/agree that Starpharma’s three SPL7013 commercialised products (Fleurstat, condoms and Viraleze) have been commercial flops so far. . FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. I think this is the start of a trail that may lead somewhere in hopefully SPL offering shareholder clearer explainations and referenced articles / posters etc in announcements being on website and then later being unavaliable is a process across the ASX that has to be stopped. Can you imagine. ASX - By Stock Forum | Join the HotCopper forum today for free. Become the CEO of Starpharma Step 2. SPL could announce tomorrow that DEP doesn’t work and they’ll still find a way to spin it positively. Forums. SPL Price at posting: $1. HotCopper is Australia's largest free and independent stock market trading forum for. Join the HotCopper ASX share market forum today for free. ASX - By Stock. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Join the HotCopper ASX share market forum today for free. See All Discussions. IMO the Starpharma HQ kool-aide would be tasting pretty bitter these days. Market. 5. distraction achieved. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Contacts. Ena Respiratory is getting news coverage everywhere - newspapers, onilne, 7 morning news, more coverage than I've seen for SPL - “By boosting the natural immune response of the ferrets with our treatment, we’ve seen a rapid eradication of the virus,” he explained in a statement. Working in a. DISCOVER THE BATTERY METALS. It is lengthy but well worth the time. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. 0012. Some years ago SPL failed an FDA trial for the same product when Jackie was CEO. Created with Sketch. 57. , page-3. 5. 8¢. Canadian Dollar. Created with Sketch. . SPL. Maybe some positive news coming out of Starpharma CEO's busines trip to America over coming daysFor shareholder it is a task of getting a CEO who can make hard decisions based on what does happen but with shrinking internal candidates progress it triggered red flags for me a sif you were very confident and could show progress and efficacy new candidated would and could be funded / partnered so IMO odd to close down or delay. 9¢. See All Discussions. . I have just sent. 82%)And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - Day Trading So the share price of SPL rose up to a high of $2. Canadian Dollar. The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. I have today made my own enquiries with AstraZeneca directly on 1-877-240-9479 and they (Camellia) have confirmed that this trial is not yet recruiting and she also confirmed that the day recruitment starts the status on the website will be updated. And somebody must be buying all the shares that are being sold. Imo, financial things such as deals, sales and. Created with Sketch. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial Review About this app. Latest Posts.